Peer genetic coaching for African American men with metastatic prostate cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness of a network of peer genetic coaches in improving genetic testing awareness and access among African American men diagnosed with metastatic prostate cancer. The study involves training selected individuals as peer genetic coaches who will provide education and support to their peers regarding genetic counseling and testing. The primary focus is to address barriers such as cultural beliefs and mistrust in the healthcare system that may prevent these men from seeking necessary genetic testing. The study also aims to measure changes in knowledge and attitudes towards genetic counseling among participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* AIM 1: Are 18 years old or older
* AIM 1: Are able to read and speak English comfortably
* AIM 1: Men who have experience with both prostate cancer (PCA) and genetic counseling and testing will be a priority for training, as well as men who have considerable peer education or navigation experience
* AIM 2: Are 18 years old or older
* AIM 2: Are African American
* AIM 2: Are able to read and speak English comfortably
* AIM 2: Men who meet any one of the following criteria: (1) metastatic prostate cancer; (2) prostate cancer with high-risk features (T3 or higher, Gleason 8 or higher, node positive disease); (3) with or without a diagnosis of prostate cancer with strong family history (2 or more first-degree or second-degree relatives) with prostate cancer (particularly metastatic prostate cancer or died from prostate cancer), breast cancer, ovarian cancer, pancreatic cancer, colorectal cancer, uterine cancer, renal cancer, urothelial cancer, or upper bowel cancer

Exclusion Criteria:

* Patients that do not meet the inclusion criteria
* Children under the age of 18
* Anyone who has trouble understanding the consent or with significant anxiety detected during the consent process

Where it's running

• Sidney Kimmel Cancer Center at Thomas Jefferson University
  Philadelphia, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Amy Leader, DrPh, MPH — Thomas Jefferson University
• Study coordinator: Site Public Contact
• Email: ONCTrialNow@jefferson.edu
• Phone: 215-600-9151

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home versus clinic cancer treatment for Black men with advanced or recurrent prostate cancer

  This Phase II test tries whether giving cancer treatments at home instead of in the clinic is safer and more satisfying for Black men with locally advanced, biochemically recurrent, or metastatic prostate cancer.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07073794

• Using bright white light therapy to reduce fatigue and depression in advanced prostate cancer patients

  This study is testing if bright white light therapy can help reduce fatigue and depression in men with advanced prostate cancer who are receiving treatment.

  Recruiting Phase 2 City of Hope Medical Center · Duarte, California · NCT05869682

• Carboplatin treatment before surgery for high-risk prostate cancer with BRCA mutations

  This study is testing if giving carboplatin chemotherapy before surgery can help men with high-risk prostate cancer and BRCA mutations have better outcomes.

  Recruiting at 132 sites Phase 2 SWOG Cancer Research Network · Anchorage, Alaska and 132 other locations · NCT05806515

• Peer navigation to support African American men with metastatic prostate cancer during genetic testing

  This trial tests whether a trained peer navigator helps African American men with metastatic prostate cancer better understand and complete genetic testing compared with standard care.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT05487846

• Effects of vitamin D replacement on immune function in Black prostate cancer patients

  This study is testing if giving vitamin D to Black men with prostate cancer can help their immune system work better and improve their overall health.

  Recruiting at 2 sites Early Phase 1 Mayo Clinic · Scottsdale, Arizona and 1 other locations · NCT05045066

• Androgen therapy with or without niraparib for high-risk prostate cancer after radiation

  This study is testing whether adding the drug niraparib to hormone therapy after radiation can help men with high-risk prostate cancer do better than hormone therapy alone.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT04947254

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.